Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice
- PMID: 15265669
- DOI: 10.1016/j.jneuroim.2004.04.015
Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice
Abstract
FTY720 is a prodrug for FTY-phosphate, an agonist at four of the five known receptors for sphingosine-1-phosphate (S1P). We show that administration of either FTY720 or FTY-P to SJL mice with established relapsing-remitting experimental autoimmune encephalitis (EAE) results in a rapid and sustained improvement in their clinical status, and a reversal of changes in expression of mRNAs encoding some myelin proteins and inflammatory mediators. EAE produced by adoptively transferring lymph node cells from immunized mice to naïve hosts is similarly ameliorated by FTY-P. Treatment with FTY-P is accompanied by a dose-responsive peripheral lymphopoenia.
Similar articles
-
Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis.Int Immunopharmacol. 2011 Mar;11(3):366-72. doi: 10.1016/j.intimp.2010.10.005. Epub 2010 Oct 16. Int Immunopharmacol. 2011. PMID: 20955831
-
FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration.Cell Mol Immunol. 2005 Dec;2(6):439-48. Cell Mol Immunol. 2005. PMID: 16426494
-
FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses.J Neurosci Res. 2010 Feb 1;88(2):346-59. doi: 10.1002/jnr.22196. J Neurosci Res. 2010. PMID: 19658199
-
Central nervous system-directed effects of FTY720 (fingolimod).J Neurol Sci. 2008 Nov 15;274(1-2):13-7. doi: 10.1016/j.jns.2008.06.031. Epub 2008 Aug 3. J Neurol Sci. 2008. PMID: 18678377 Review.
-
FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.Pharmacol Ther. 2005 Dec;108(3):308-19. doi: 10.1016/j.pharmthera.2005.05.002. Epub 2005 Jun 13. Pharmacol Ther. 2005. PMID: 15951022 Review.
Cited by
-
A2 B Adenosine Receptors and Sphingosine 1-Phosphate Signaling Cross-Talk in Oligodendrogliogenesis.Front Neurosci. 2021 May 26;15:677988. doi: 10.3389/fnins.2021.677988. eCollection 2021. Front Neurosci. 2021. PMID: 34135730 Free PMC article. Review.
-
Fingolimod: a review of its use in the management of relapsing-remitting multiple sclerosis.CNS Drugs. 2011 Aug;25(8):673-98. doi: 10.2165/11207350-000000000-00000. CNS Drugs. 2011. PMID: 21790210 Review.
-
"Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets.Pharmacol Rev. 2008 Jun;60(2):181-95. doi: 10.1124/pr.107.07113. Epub 2008 Jun 13. Pharmacol Rev. 2008. PMID: 18552276 Free PMC article. Review.
-
Lysophospholipid receptors in neurodegeneration and neuroprotection.Explor Neuroprotective Ther. 2024;4(4):349-365. doi: 10.37349/ent.2024.00088. Epub 2024 Aug 22. Explor Neuroprotective Ther. 2024. PMID: 39247084 Free PMC article.
-
Safety and efficacy of fingolimod in treatment-naïve multiple sclerosis patients.J Cent Nerv Syst Dis. 2011 Mar 16;3:43-50. doi: 10.4137/JCNSD.S5120. Print 2011. J Cent Nerv Syst Dis. 2011. PMID: 23861637 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources